Screening for Urinary Incontinence by Primary Care Providers
NCT00178334
ABOUT THIS STUDY
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
Pfizer Clinical Trials Contact Center
1-800-718-1021
- All primary care providers in the Greater Rochester metropolitan area, including: Primary care Medical Doctors (MD), Doctors of Osteopathy (DO), Primary care Nurse Practitioners (NP), and Physician Assistants (PA)
- Physicians in the Greater Rochester metropolitan area who are not primary care
providers
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Boston, Massachusetts
- Boston, Massachusetts
- Beijing, Beijing
- Beijing, Beijing
- Huangzhou, Zhejiang
- Beijing,
- Chongqing,
- Shanghai,
- Shanghai,
- Chandler, Arizona
- Phoenix, Arizona
- Little Rock, Arkansas
- Berkeley, California
- Oakland, California
- San Diego, California
- San Francisco, California
- Santa Rosa, California
- Denver, Colorado
- Denver, Colorado
- Lakewood, Colorado
- Farmington, Connecticut
- West Hartford, Connecticut
- Clearwater, Florida
- Leesburg, Florida
- Miami, Florida
- Pembroke Pines, Florida
- West Palm Beach, Florida
- Weston, Florida
- Alpharetta, Georgia
- Evansville, Indiana
- Newburgh, Indiana
- South Bend, Indiana
- Baton Rouge, Louisiana
- Metairie, Louisiana
- Metairie, Louisiana
- Baltimore, Maryland
- Saginaw, Michigan
- Creve Coeur, Missouri
- Las Vegas, Nevada
- Las Vegas, Nevada
- North Las Vegas, Nevada
- New Brunswick, New Jersey
- Albuquerque, New Mexico
- Olean, New York
- New Bern, North Carolina
- Winston-Salem, North Carolina
- Cincinnati, Ohio
- Cincinnati, Ohio
- Cleveland, Ohio
- Cleveland, Ohio
- Columbus, Ohio
- Gallipolis, Ohio
- Allentown, Pennsylvania
- Philadelphia, Pennsylvania
- Columbia, South Carolina
- Austin, Texas
- Austin, Texas
- Austin, Texas
- Bryan, Texas
- Conroe, Texas
- Irving, Texas
- San Antonio, Texas
- Salt Lake City, Utah
- Salt Lake City, Utah
- Seattle, Washington
- Morgantown, West Virginia
- Morgantown, West Virginia
Descriptive Information | ||||
---|---|---|---|---|
Brief Title | Screening for Urinary Incontinence by Primary Care Providers | |||
Official Title | Screening for Urinary Incontinence by Primary Care Providers | |||
Brief Summary | The purpose of this study is to:
| |||
Detailed Description | UI is a very common condition whose prevalence can be expected to increase dramatically in the coming decades. Treatment options are available to improve women's health and quality of life. However, inadequate communication between physicians and patients leads to decreased diagnosis and treatment. Past studies evaluating the use of screening by primary care providers, who act as gatekeepers in our healthcare system, clearly demonstrate that improvements must be made in the screening system. We propose a survey of local primary care providers to quantify screening rates for UI and identify barriers to successful screening. The information collected in this survey will allow us to identify methods such as targeted education opportunities and patient literature or questionnaires that will assist providers and their patients in initiating discussion and evaluation of UI. | |||
Study Type | Observational | |||
Study Design | Observational Model: Cohort Time Perspective: Prospective | |||
Target Follow-Up Duration | Not Provided | |||
Biospecimen | Not Provided | |||
Sampling Method | Probability Sample | |||
Study Population | Primary care providers | |||
Condition | Urinary Incontinence | |||
Intervention | Not Provided | |||
Study Groups/Cohorts | Not Provided | |||
Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | ||||
Recruitment Information | ||||
Recruitment Status | Completed | |||
Actual Enrollment | 554 | |||
Original Enrollment | 1500 | |||
Actual Study Completion Date | July 2006 | |||
Actual Primary Completion Date | July 2006 (Final data collection date for primary outcome measure) | |||
Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
| |||
Sex/Gender |
| |||
Ages | 21 Years and older (Adult, Older Adult) | |||
Accepts Healthy Volunteers | Yes | |||
Contacts | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries | Not Provided | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number | NCT00178334 | |||
Other Study ID Numbers | 11355 | |||
Has Data Monitoring Committee | No | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement | Not Provided | |||
Responsible Party | Gunhilde Buchsbaum, University of Rochester | |||
Study Sponsor | University of Rochester | |||
Collaborators | Pfizer | |||
Investigators |
| |||
PRS Account | University of Rochester | |||
Verification Date | January 2013 |